Company Analysis

Bausch + Lomb Corporation (BLCO)

NYSE: BLCO · Ophthalmic Goods · Vaughan, ON · filing with the SEC since 2021
Grade4.9
◀ Past 5.8● Present 5.2▶ Future 3.7

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

1,104 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bausch + Lomb Corporation’s names, not what it holds today.

Patents granted
1,104
914 utility, 186 design, 4 reissue, 1976 to Dec 31, 2025
Granted in 2025
4
Against 2 in 2024 and 7 in 2023
Applications published
263
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology11
Other special machines6
Macromolecular chemistry, polymers4
Pharmaceuticals4
Optics3
Handling1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
BAUSCH & LOMB INCORPORATED its own name
US, as the owner printed on each patent
1,104 granted
197 published
Bausch & Lomb Incorporated its own name
named as the applicant on its applications, in US
0 granted
66 published
Names not counted (24)
Synergetics, Inc.
Also listed as a subsidiary by Bausch Health Companies Inc.. 52 granted and 23 published under it are not counted.
Bausch + Lomb Ireland Limited
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 68 published under it are not counted.
AcuFocus, Inc.
Also listed as a subsidiary by Bausch Health Companies Inc.. 42 granted and 12 published under it are not counted.
Bausch + Lomb Ireland Limited
Also listed as a subsidiary by Bausch Health Companies Inc.. 34 granted and 14 published under it are not counted.
Technolas Perfect Vision GmbH
Also listed as a subsidiary by Bausch Health Companies Inc.. 41 granted and 4 published under it are not counted.
AcuFocus, Inc.
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 35 published under it are not counted.
ELIOS Vision GmbH
Also listed as a subsidiary by Bausch Health Companies Inc.. 17 granted and 16 published under it are not counted.
ELIOS Vision GmbH
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 21 published under it are not counted.
Synergetics, Inc.
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 18 published under it are not counted.
Kedalion Therapeutics, Inc.
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 15 published under it are not counted.
Technolas Perfect Vision GmbH
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 10 published under it are not counted.
Paragon BioTeck, Inc.
Also listed as a subsidiary by Bausch Health Companies Inc.. 0 granted and 9 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 23, 202512,419,990Ophthalmic viscoelastic compositionsMedical technologyBAUSCH & LOMB INCORPORATED
Sep 23, 202512,419,784Ultrasonic surgical aspiration needle assembly with molded hubMedical technologyBAUSCH & LOMB INCORPORATED
Aug 12, 202512,386,200Method for obtaining contact lenses with dynamically controlled sagitta and clearanceOpticsBAUSCH & LOMB INCORPORATED
Feb 18, 202512,227,598Glycophospholipid polymeric network and use thereofPharmaceuticalsBAUSCH & LOMB INCORPORATED
Oct 29, 202412,127,935Intraocular lens injector assembly having shuttle assembly retaining intraocular lens in storage vial and operably presenting intraocular lens in injector assemblyMedical technologyBAUSCH & LOMB INCORPORATED
Feb 13, 202411,897,985Water extractable ophthalmic devicesOther special machinesBAUSCH & LOMB INCORPORATED
Dec 19, 202311,845,813Crosslinked polymeric network and use thereofMacromolecular chemistry, polymersBAUSCH & LOMB INCORPORATED
Sep 12, 202311,752,035Ultrasonic needles and transducer assemblies formed of non-metal materials or a combination of materialsMedical technologyBAUSCH & LOMB INCORPORATED
Aug 22, 202311,732,060Crosslinked polymeric network and use thereofMacromolecular chemistry, polymersBAUSCH & LOMB INCORPORATED
Jul 18, 202311,701,222Injector assembly employing compressed gas and a mechanical brake for presenting an intraocular lens to a patientMedical technologyBAUSCH & LOMB INCORPORATED
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 15, 20252025/0154289GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOFPharmaceuticalsBausch & Lomb Incorporated
Feb 29, 20242024/0066181OPHTHALMIC VISCOELASTIC COMPOSITIONSMedical technologyBausch & Lomb Incorporated
Aug 17, 20232023/0257485GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOFPharmaceuticalsBausch & Lomb Incorporated · patent 12,227,598 granted from it
May 11, 20232023/0140895OPHTHALMIC SUSPENSION COMPOSITIONPharmaceuticalsBausch & Lomb Incorporated
Mar 16, 20232023/0084398METHOD FOR OBTAINING CONTACT LENSES WITH DYNAMICALLY CONTROLLED SAGITTA AND CLEARANCEOpticsBausch & Lomb Incorporated · patent 12,386,200 granted from it
Jan 19, 20232023/0017040DISTANCE DOMINANT INTRAOCULAR LENSOpticsBausch & Lomb Incorporated
Dec 29, 20222022/0409432Ultrasonic Surgical Aspiration Needle Assembly with Molded HubMedical technologyBausch & Lomb Incorporated · patent 12,419,784 granted from it
Oct 13, 20222022/0325006CROSSLINKED POLYMERIC NETWORK AND USE THEREOFMacromolecular chemistry, polymersBausch & Lomb Incorporated · patent 11,845,813 granted from it
Oct 13, 20222022/0323253RESONANT NON-SINUSOIDAL DRIVE SIGNALS FOR PHACOEMULSIFICATION SURGERY DEVICESMedical technologyBausch & Lomb Incorporated
Aug 11, 20222022/0251269WATER EXTRACTABLE OPHTHALMIC DEVICESMacromolecular chemistry, polymersBausch & Lomb Incorporated · patent 11,897,985 granted from it
What it applied for, 2024 to 2025: Medical technology 1 · Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton BLCO · research, not advice